KalVista Pharma Stock (NASDAQ: KALV) stock price, news, charts, stock research, profile.
Open | $11.180 |
Close | $10.350 |
Volume / Avg. | 482.332K / 803.805K |
Day Range | 10.320 - 11.180 |
52 Wk Range | 7.210 - 16.880 |
Market Cap | $436.649M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 32 |
Short Interest | 13.81% |
Days to Cover | 9.14 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of KalVista Pharma (NASDAQ: KALV) through any online brokerage.
Other companies in KalVista Pharma’s space includes: Humacyte (NASDAQ:HUMA), Celcuity (NASDAQ:CELC), Voyager Therapeutics (NASDAQ:VYGR), Larimar Therapeutics (NASDAQ:LRMR) and Altimmune (NASDAQ:ALT).
The latest price target for KalVista Pharma (NASDAQ: KALV) was reported by Needham on Thursday, April 11, 2024. The analyst firm set a price target for 35.00 expecting KALV to rise to within 12 months (a possible 238.16% upside). 8 analyst firms have reported ratings in the last year.
The stock price for KalVista Pharma (NASDAQ: KALV) is $10.35 last updated Today at April 24, 2024 at 4:00 PM EDT.
There are no upcoming dividends for KalVista Pharma.
KalVista Pharma’s Q4 earnings are confirmed for Friday, July 5, 2024.
There is no upcoming split for KalVista Pharma.
KalVista Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.